Cargando…

Acetovanillone augmented the cardioprotective effect of carvedilol against cadmium-induced heart injury via suppression of oxidative stress and inflammation signaling pathways

Cardiac toxicity is a public health issue that can be caused by both environmental and occupational exposures. The current study aimed to investigate the effectiveness of carvedilol (CV), Acetovanillone (ACET), and their combination for ameliorating cadmium (Cd)-induced oxidative stress, inflammatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hassanein, Emad H. M., Bakr, Adel G., El-Shoura, Ehab A. M., Ahmed, Lamiaa Khalaf, Ali, Fares E. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10066216/ https://www.ncbi.nlm.nih.gov/pubmed/37002251 http://dx.doi.org/10.1038/s41598-023-31231-5

Ejemplares similares

Edaravone and Acetovanillone Upregulate Nrf2 and PI3K/Akt/mTOR Signaling and Prevent Cyclophosphamide Cardiotoxicity in Rats
por: Hassanein, Emad H M, et al.
Publicado: (2020)

Bacterial catabolism of acetovanillone, a lignin-derived compound
por: Dexter, Gara N., et al.
Publicado: (2022)

Antidiarrheal activities of isovanillin, iso-acetovanillon and Pycnocycla spinosa Decne ex.Boiss extract in mice
por: Sadraei, H., et al.
Publicado: (2014)

Matrix Metalloproteinase-2 Inhibition in Acute Ischemia-Reperfusion Heart Injury—Cardioprotective Properties of Carvedilol
por: Skrzypiec-Spring, Monika, et al.
Publicado: (2021)

Combined β-sitosterol and trimetazidine mitigate potassium dichromate-induced cardiotoxicity in rats through the interplay between NF-κB/AMPK/mTOR/TLR4 and HO-1/NADPH signaling pathways
por: El-Shoura, Ehab A. M., et al.
Publicado: (2023)

Enantioselective Resolution of (R,S)-Carvedilol to (S)-(−)-Carvedilol by Biocatalysts
por: Ettireddy, Swetha, et al.
Publicado: (2017)

Photobiomodulation therapy combined with carvedilol attenuates post-infarction heart failure by suppressing excessive inflammation and oxidative stress in rats
por: Grandinetti, Vanessa, et al.
Publicado: (2019)

Carvedilol in the treatment of chronic heart failure: Lessons from The Carvedilol Or Metoprolol European Trial
por: Kveiborg, Britt, et al.
Publicado: (2007)

Carvedilol in hypertension treatment
por: Stafylas, Panagiotis C, et al.
Publicado: (2008)

Carvedilol—NSBB of Choice in All Cirrhotics? Short Title: Carvedilol for Portal Hypertension
por: Tandon, Puneeta, et al.
Publicado: (2015)

Carvedilol Selectively Stimulates βArrestin2-Dependent SERCA2a Activity in Cardiomyocytes to Augment Contractility
por: Maning, Jennifer, et al.
Publicado: (2022)

Cardioprotection by adaptation to ischaemia augments autophagy in association with BAG-1 protein
por: Gurusamy, Narasimman, et al.
Publicado: (2009)

Carvedilol in the treatment of elderly patients with chronic heart failure
por: Witte, Klaus KA, et al.
Publicado: (2008)

Immunopharmacological Approach of Carvedilol in Chronic Chagas Heart Disease
por: Miranda, Carla Paixão, et al.
Publicado: (2014)

Use of carvedilol in hypertension: an update
por: Leonetti, Gastone, et al.
Publicado: (2012)

Carvedilol in the Treatment of Portal Hypertension
por: Al-Ghamdi, Hamdan
Publicado: (2011)

Candesartan Protects Against Cadmium-Induced Hepatorenal Syndrome by Affecting Nrf2, NF-κB, Bax/Bcl-2/Cyt-C, and Ang II/Ang 1–7 Signals
por: Kamel, Esam O., et al.
Publicado: (2022)

Cardioprotective Potential of Garlic Oil and Its Active Constituent, Diallyl Disulphide, in Presence of Carvedilol during Chronic Isoprenaline Injection-Mediated Myocardial Necrosis in Rats
por: Asdaq, Syed Mohammed Basheeruddin, et al.
Publicado: (2021)

Proinflammatory impact of norepinephrine in cardiomyocytes: increased interleukin-6 production, which is suppressed by carvedilol
por: Müller-Werdan, U, et al.
Publicado: (1999)

Suppression of Myocardial Injury Markers following Percutaneous Coronary Interventions by Pre-treatment with Carvedilol
por: Moloudi, Abdolrasoul, et al.
Publicado: (2012)

Hypertensive heart disease: Benefit of carvedilol in hemodynamic, left ventricular remodeling, and survival
por: Dominguez, Renata F, et al.
Publicado: (2019)

Preclinical Evidences for an Antimanic Effect of Carvedilol
por: de Souza, Greicy Coelho, et al.
Publicado: (2015)

Carvedilol for the treatment of red scrotum syndrome
por: Merhi, Ribal, et al.
Publicado: (2017)

Hot Melt Coating of Amorphous Carvedilol
por: Bannow, Jacob, et al.
Publicado: (2020)

Synthesis of Carvedilol–Organotin Complexes and Their Effects on Reducing Photodegradation of Poly(Vinyl Chloride)
por: Mousa, Omar G., et al.
Publicado: (2021)

Cardioprotective effect of carvedilol: inhibition of apoptosis in H9c2 cardiomyocytes via the TLR4/NF-κB pathway following ischemia/reperfusion injury
por: ZHAO, YONG, et al.
Publicado: (2014)

Lansoprazole attenuates cyclophosphamide-induced cardiopulmonary injury by modulating redox-sensitive pathways and inflammation
por: Hassanein, Emad H. M., et al.
Publicado: (2023)

The Neuroprotective Effect of Carvedilol on Diabetic Neuropathy: An In Vitro Study
por: Magadmi, Rania M., et al.
Publicado: (2021)

The β-Blocker Carvedilol Prevents Benzo(a)pyrene-Induced Lung Toxicity, Inflammation and Carcinogenesis
por: Shahid, Ayaz, et al.
Publicado: (2023)

A simple LC-MS/MS method for pharmacokinetic study of carvedilol and 4/-hydroxyphenyl carvedilol at a low dose
por: Eiamart, Wanna, et al.
Publicado: (2022)

Effect of Carvedilol on Reduction in Heart Rate in Patients With Chronic Atrial Fibrillation
por: Kodani, Eitaro, et al.
Publicado: (2013)

Liposomal Resveratrol and/or Carvedilol Attenuate Doxorubicin-Induced Cardiotoxicity by Modulating Inflammation, Oxidative Stress and S100A1 in Rats
por: Alanazi, Abeer M., et al.
Publicado: (2020)

Effect of hydroxylpropyl-β-cyclodextrin on Solubility of Carvedilol
por: Shewale, B. D., et al.
Publicado: (2008)

Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol
por: Barold, S. Serge, et al.
Publicado: (2018)

Preventive role of carvedilol in adriamycin-induced cardiomyopathy
por: Jhorawat, Rajesh, et al.
Publicado: (2016)

Carvedilol versus Metoprolol in Patients with Ventricular Tachyarrhythmias
por: Schupp, Tobias, et al.
Publicado: (2022)

How Carvedilol activates β(2)-adrenoceptors
por: Benkel, Tobias, et al.
Publicado: (2022)

Prophylactic use of carvedilol to prevent ventricular dysfunction in patients with cancer treated with doxorubicin
por: Abuosa, Ahmed Mohamed, et al.
Publicado: (2018)

Carvedilol Exerts Neuroprotective Effect on Rat Model of Diabetic Neuropathy
por: Magadmi, Rania M., et al.
Publicado: (2021)

Protective effects of thymoquinone and l-cysteine on cadmium-induced reproductive toxicity in rats
por: Sayed, Manal M., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tdbcljdeo974c1v58iehjemlk0